SS
Insider
Saurabh Saha
DirectorSaurabh Saha (Director) filed 13 Form 4 reports in the past 24 months (1 purchase, 12 sales), most often in Centessa Pharmaceuticals plc (CNTA). Across 1 priced purchase filing, the average 21-session return was -8.8% from execution and -3.4% from disclosure (delay-adjusted; derived). The largest single filing was $1.6M of CNTA (87,496 sh × $18.46, as filed), executed Dec 6 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-8.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-3.4%
same 1 filings, from disclosure
Filings, ttm
13
1 buys · 12 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.7M
shares × price, as filed
Last traded
Jul 21 2025
Filed Jul 21 2025
Median ADV $76.8M across their filed names
Open performance→Volume by month
Buys $254K
Sells $10.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Technology
1 filing
Sector per market data · by filing · past 24 months
Most traded names
CNTA
Centessa Pharmaceuticals plc
CNTA · 0 buys · 12 sells
12 filings
CLVTRecent filings
CNTASALE
Centessa Pharmaceuticals plc
View filing →
$876K55,000 sh × $15.92
Exec Jul 21 2025
Filed Jul 21 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $695K
55,000 sh × $12.63
Exec Jun 20 2025
Filed Jun 20 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $699K
55,000 sh × $12.71
Exec May 20 2025
Filed May 20 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $682K
55,000 sh across 2 lots
Exec Apr 21 2025
Filed Apr 22 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $918K
55,000 sh × $16.69
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET CLVTPURCHASE Clarivate Plc View filing → $254K
58,275 sh × $4.36
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $863K
54,225 sh × $15.92
Exec Feb 20 2025
Filed Feb 20 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $841K
53,375 sh × $15.76
Exec Jan 21 2025
Filed Jan 22 2025 · 5:30 PM ET More filings →